// App-Quantinova.ai

SAT0189 (2018) : Dynamics of circulating tnf during adalimumab treatment of rheumatoid arthritis using a novel drug-tolerant tnf assay

Researchers

Presenter

  • L. C. Berkhout

Principal Investigators

  • M. J. l'Ami

  • J. Ruwaard

  • M. H. Hart

  • P. Ooijevaar-de Heer

  • K. Bloem

  • M. T. Nurmohamed

  • R. F. van Vollenhoven

  • M. Boers

  • C. Smith

  • G. Wolbink

  • T. Rispens

Medical Centers

  • Department of Immunopathology,Sanquin Research an

  • Amsterdam Rheumatology and immunology Center

  • Amsterdam Rheumatology and immunology Center, VU University Medical Center

  • Amsterdam Rheumatology and immunology Center, VU University Medical Center

  • Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, Netherlands

  • St. John's Institute of Dermatology, Division of Genetics and Molecular Medicine, Kings College London, London, UK

Locations

  • Netherlands

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • Tumor necrosis factor

Drug/Treatment

  • Adalimumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Abbvie

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved